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Abstract
Purpose—To examine known-groups validity of the Patient-Reported Outcomes Measurement 
Information System (PROMIS®) Short Forms (SFs) for adolescents and young adults with special 
health care needs (SHCN) using data collected from the PROMIS Linking Study.
Methods—292 adolescents aged 14–17.9 years and 300 young adults aged 18–20 years with 
SHCN from the PROMIS Linking Study were used for analyses. Presence of SHCN was classified 
into 3 categories (medication use, service use, and functional limitations). HRQoL was measured 
with the PROMIS Pediatric and Adult SFs. Differences in health-related quality of life (HRQoL) 
domain scores between SHCN sample and the norms of the PROMIS pediatric and adult 
calibration samples, respectively, were compared using t-tests. Associations of HRQoL scores 
with the presence of individual SHCN categories were tested using linear regression.
Corresponding author: I-Chan Huang, PhD, Department of Epidemiology and Cancer Control, MS 735, St. Jude Children's 
Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, ; Email: i-chan.huang@stjude.org, Phone: (901) 595-8369, Fax: 
(901) 595-5845
Harry A. Guess, MD, PhD (deceased)
Alan Jette, PT, PhD, Stephen M. Haley, PhD (deceased)
Vanessa Ameen, MD (deceased)
Conflict of interest:
No conflict of interest to all co-authors.
Ethical approval:
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional 
and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. 
The University of Florida Institution Review Board approved the study protocol. Informed consent was obtained from all individual 
participants included in the study.
HHS Public Access
Author manuscript
Qual Life Res. Author manuscript; available in PMC 2017 July 01.
Published in final edited form as:
Qual Life Res. 2016 July ; 25(7): 1815–1823. doi:10.1007/s11136-016-1237-2.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results—All HRQoL domain scores for the SHCN samples were significantly worse than the 
respective calibration samples. Adolescents and young adults with SHCN-related service use and 
functional limitations reported worse HRQoL than those without service use and functional 
limitations (p’s<0.01).
Conclusions—PROMIS Pediatric and Adult SFs possess satisfactory known-groups validity 
related to SHCN status.
Keywords
Adolescents; Health-Related Quality of Life; Patient-Reported Outcomes Measurement 
Information System (PROMIS®); Special Health Care Needs; Young Adults
INTRODUCTION
Approximately 13% of children and youth in the US are living with special health care 
needs (SHCN) status [1], with 750,000 SHCN youth transitioning to adulthood each year 
[2]. SHCN is defined as individuals who have or are at risk for chronic physical, emotional, 
and developmental conditions that require health services at a rate higher than individuals 
without chronic conditions [3]. Health-related quality of life (HRQoL) is an important 
indicator to quantify outcomes of individuals with SHCN [4–6]. Patient-Reported Outcomes 
Measurement Information System (PROMIS®) [7] was designed to measure HRQoL and 
allows for tracking HRQoL changes over time including the transition from adolescence into 
adulthood. However, the comparative validity of the PROMIS scales between SHCN 
adolescents and young adults has not been established.
This study aimed to test the known-groups validity related to SHCN status for the PROMIS 
Pediatric and Adult Short Forms (SFs) in adolescents and young adults. Known-groups 
validity describes the ability of a scale to distinguish HRQoL between subgroups based on 
meaningful anchors [8]. First, we compared HRQoL of SHCN samples to the norms of the 
PROMIS pediatric [9] and adult calibration samples [10, 11]. We hypothesize that SHCN 
individuals will exhibit poorer HRQoL than the calibration samples. Second, we compared 
HRQoL in SHCN individuals by the presence of specific categories of SHCN [12]. We 
hypothesize that individuals with impairment in a specific SHCN category will exhibit 
poorer HRQoL than those without impairment.
METHODS
Study Design and Population
This study was a secondary data analysis based on the NIH-funded PROMIS Linking Study 
[13] that aimed to link the PROMIS Pediatric and Adult SFs to create comparable scores 
across adolescence and adulthood. In total, 292 adolescents and 300 young adults were 
recruited from the Texas Medicaid and Children’s Health Insurance Program and the 
Opinions for Good panel. Inclusion criteria were 14–17 years of age (adolescents) and 18–
20 years of age (young adults), identification with SHCN, and ability to communicate in 
English. SHCN status was assessed through the SHCN Screener (see below). An e-mail was 
sent to young adults for consent, and to parents of adolescents for consent and adolescents 
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for assent. Following consent, adolescents and young adults were asked to complete a 40-
minute online survey. The protocol was approved by the Institutional Review Board of the 
University of Florida (data collection site).
Measures
SHCN Screener—The SHCN screener assesses 5 health consequences: 1) medication use; 
2) use of medical, mental, and behavioral health services; 3) functional limitations that 
restrict individuals from participating in activities at the rate which unimpaired individuals 
do; 4) use of special therapy; and 5) use of treatment or counseling for emotional and 
developmental problems. After answering each main question, participants were asked: 1) 
whether the consequence is due to a specific health condition (i.e. physical, mental, 
behavioral) and 2) whether the condition is expected to last (or has lasted) at least 12 
months. Three definitional categories of SHCN were further created: 1) medication use, 2) 
service use (i.e., use of medical, mental, and behavioral health services, special therapy, or 
treatment and/or counseling for emotional and developmental problems), and 3) functional 
limitations [14, 15]. The Screener possesses good psychometric properties [16] and is able to 
discriminate between individuals with and without chronic conditions [17].
PROMIS SFs—The PROMIS Pediatric and Adult SFs [7] were used to measure HRQoL. 
Adolescents completed eight pediatric SFs and young adults completed seven adult SFs (see 
online supplement). Both Pediatric and Adult SFs contain similar HRQoL constructs of 
depressive symptoms, anxiety, anger, pain interference, and fatigue; peer relationships for 
adolescents which is conceptually similar to social health for adults; and mobility and upper 
extremity for adolescents which is comparable to physical functioning for adults. A recall 
period of the past seven days was used for all items. Scores for each SF were summed and 
converted to a T-metric with a mean of fifty and a standard deviation of ten based on the 
original pediatric [9] and adult calibration samples [10, 11]. The PROMIS SFs have shown 
good psychometric properties for the Pediatric [18] and Adult SFs [19].
Statistical Methods
Overall, age-specific and gender-specific mean PROMIS SF scores of adolescent 
participants were compared to the norms of the PROMIS pediatric calibration sample (mean 
50 and standard deviation 10) [9], and the overall and gender-specific mean PROMIS SF 
scores of the young adult participants were compared to the norms of the PROMIS adult 
calibration sample (mean 50 and standard deviation 10) [10, 11]. PROMIS adult calibration 
sample is representative of the US general population based on the sampling strategies and 
participant characteristics. Each participant was classified by presence of three definitional 
categories, separately. Independent sample t-tests were used to test differences in mean 
HRQoL domain scores by presence of individual SHCN categories. Multiple regression was 
performed to examine associations between presence of each SHCN category and each 
HRQoL domain with and without adjusting for covariates (age, gender, ethnicity, education, 
and chronic conditions).
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RESULTS
Adolescents had a mean age of 15.5 years (SD: 1.1), and 50.3% were female. Young adults 
had a mean age of 19.0 years (SD: 0.8), and 50.7% were female (Table 1). All HRQoL 
domain scores of SHCN adolescent and young adult samples were significantly impaired 
compared with the norms of the pediatric calibration sample and the adult calibration sample 
(Figure 1). Likewise, age-specific (Figure 1) and gender-specific HRQoL of SHCN 
adolescent and young adult samples (Figure 2) were significantly impaired compared to the 
respective pediatric and adult calibration samples, except for pain interference SF in 
adolescent males. Adolescents and young adults with SHCN who indicated service use and 
functional limitations reported worse HRQoL scores on all SFs (p’s<0.01) than those who 
did not indicate using services or having functional limitations, except for social health SF in 
young adults (Table 2).
Multivariate analyses reveal functional limitation category was a significant predictor of 
worse HRQoL scores across all SFs (p’s<0.05) in both adolescents and young adults, except 
for social health in young adults (Model 1, Table 3). Service use was a significant predictor 
of worse HRQoL scores for all SFs in adolescents (p’s<0.05) and for anxiety, fatigue, pain 
interference, and physical functioning SFs (p’s<0.01) in young adults. Specifically, the 
magnitude of effect was higher in adolescents (vs. young adults) for service use category and 
higher for functional limitations category in young adults (vs. adolescents). Adolescent 
males reported better HRQoL scores on anxiety, fatigue, pain interference, mobility and 
upper extremity SFs than females (p’s<0.05) (Model 2, Table 3). Hypertension was 
associated with worse HRQoL scores among adolescents and young adults, with greater 
significance and magnitudes in adolescents across all SFs. Without covariates, the status of 
three SHCN categories explained the most variance in adolescents in anxiety and mobility 
(R2: 17% and 18%, respectively) while the three categories of SHCN explained more 
variance in young adults in pain interference and physical functioning (R2: 21% and 24%, 
respectively) (Model 1, Table 3).
DISCUSSION
Both PROMIS Pediatric and Adult SFs were able to discriminate between people with and 
without the presence of specific SHCN categories. Adolescents and young adults with 
SHCN reported worse HRQoL than the norms of the PROMIS pediatric adult calibration 
samples, respectively, across all PROMIS SFs. Our results parallel the previous 
investigations where SHCN individuals reported poorer HRQoL than non-SHCN 
counterparts [20–22]. The differences in HRQoL between our SHCN samples and the 
calibration samples may be in part due to various characteristics. Compared to the 
calibration samples, SHCN adolescents were characterized with older ages and more chronic 
conditions, and SHCN young adults were characterized with racial/ethnic minorities.
The PROMIS SFs did not distinguish medication use domain within SHCN individuals and 
this association was not statistically significant in the regression models. Similar to a 
previous study [16], this finding suggests a lower discriminatory power of the medication 
use domain related to the underlying health status compared to service use and functional 
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limitations domains of the SHCN screener. This non-significant finding also implies the 
effective medication use on the illness and disease control that leads to better functional 
status and HRQoL. The PROMIS Social Health SF was not able to discriminate within 
SHCN young adults classified as service use or functional limitations. Although one 
previous study has shown acceptable known-groups validity of PROMIS Social Health SF in 
an older adult sample with chronic conditions [23], our findings suggest that the PROMIS 
Social Health SF may lack sensitivity to this dimension for younger adults with SHCN, and 
the contents of emotional support between younger and older adults with SHCN or chronic 
conditions may not be the same. Future qualitative investigation is warranted to address this 
issue.
SHCN explained more variance in anxiety and mobility domain scores for adolescents and 
more variance in pain interference and mobility domain scores for adults. This difference 
may be explained by developmental experiences in adolescents and young adults [24, 25]. 
Adolescence is an important stage of developing personality identity and independence, 
experiencing SHCN in adolescence can result in anxiety. In contrast, the greater association 
of SHCN with pain interference in adults than in adolescents may be due to pain being more 
prevalent and severe in young adults than in adolescents [26, 27].
In sum, HRQoL in adolescents and young adults measured by the PROMIS SFs were worse 
than the norms of the calibration samples. Additionally, PROMIS SFs were able to 
discriminate between individuals classified by specific categories of SHCN. The robust 
known-groups validity related to SHCN status supports the application of PROMIS SFs in 
future research and practice.
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Figure 1. 
Comparison of SHCN adults to the norms of the PROMIS adult calibration sample overall, 
and SHCN adolescents to the norms of the PROMIS pediatric calibration sample overall and 
by age subgroups†‡
†: Lower scores indicate worse HRQoL for peer relationships, mobility, and upper 
extremity; higher scores indicate worse HRQoL for other domains
‡: Upper and lower bars indicate the 95% confidence interval range
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Figure 2. 
Comparison of SHCN adolescents to norms of the PROMIS pediatric calibration sample, 
and SHCN adults to norms of the PROMIS adult calibration sample by gender subgroups†‡
†: Lower scores indicate worse HRQoL for peer relationships, mobility, and upper 
extremity; higher scores indicate worse HRQoL for other domains
‡: Upper and lower bars indicate the 95% confidence interval range
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Table 1
Participant Characteristics (N=592)
Adolescents
(N=292)
PROMIS pediatric calibration
sample (N=4,129)
Age, mean (SD) 15.5 (1.1) NA
Age group
    8–12 NA 55.4%
    13–17 100%a 44.4%
Female, % 50.3% 50.6%
Race, %
  White 51.7%b 58.1%
  Black 25.3%b 23.2%
  Other 25.7%b 15.7%
Ethnicity, %
  Hispanic 25.0% 17.0%
  Non-Hispanic 75.0% 82.1%
Chronic Conditions (Top Five), %
  Attention-deficit/hyperactivity disorder (ADHD) 36.0%c 4.6%c
  Hypertension 27.1%c NA
  Mental Health 24.7%c 2.2%c
  Allergies 19.9%c 1.2%c
  Asthma 19.5%c 18.0%c
Adults
(N=300)
PROMIS adult calibration
sample (N=14,128)
Age, mean (SD) 19.0 (0.8) NA
Age group
    18–29 100%d 22.0%
    30–44 NA 32.0%
    45–59 NA 24.0%
    60+ NA 22.0%
Female, % 50.7% 52.0%
Race, %
  White 52.0%b 74.0%
  Black 25.3%b 11.0%
  Other 26.7%b 4%
Ethnicity, %
  Hispanic 27.0% 11.0%
  Non-Hispanic 73.0% 89.0%
Chronic Conditions (Top Five), %
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  Hypertension 32.7%c NA
  Attention-deficit/hyperactivity disorder (ADHD) 31.3%c NA
  Mental Health 20.0%c NA
  Asthma 19.0%c NA
  Allergies 14.3%c NA
a
: Our sample restricted to 14–17.9 years of age
b
: Race over 100% due to multiple choices
c
: Chronic conditions were self-reported by parents (for SHCN adolescents) and SHCN young adults
d
: Our sample restricted to 18–20 years of age
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